Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 291041011000036116 | reteplase 17.4 mg injection, 10 units vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 291042011000036110 | reteplase 10 units (17.4 mg) injection, 10 units vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| reteplase 10 units (17.4 mg) injection, 10 units vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| reteplase 10 units (17.4 mg) injection, 10 units vial | Is a | reteplase | true | Inferred relationship | Some | ||
| reteplase 10 units (17.4 mg) injection, 10 units vial | has intended active ingredient | reteplase | true | Inferred relationship | Some | 726895916 | |
| reteplase 10 units (17.4 mg) injection, 10 units vial | has Australian BoSS | reteplase | true | Inferred relationship | Some | 726895916 | |
| reteplase 10 units (17.4 mg) injection, 10 units vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| reteplase 10 units (17.4 mg) injection, 10 units vial | has unit of use | vial | true | Inferred relationship | Some | 726895917 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Rapilysin (reteplase 10 units (17.4 mg)) powder for injection, 10 units vial | Is a | True | reteplase 10 units (17.4 mg) injection, 10 units vial | Inferred relationship | Some | |
| reteplase 10 units (17.4 mg) injection [2 x 10 unit vials] (&) inert substance diluent [2 x 10 mL syringes], 1 pack | has MPUU | True | reteplase 10 units (17.4 mg) injection, 10 units vial | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR